PI3Kδ inhibitor YY‑20394 is effective alone or in combination with Bcl‑2 inhibitor ABT199 in acute myeloid leukemia cells
Oncology Reports · 17.06.2026 · 56 (2) · 1-11
DOI: 10.3892/or.2026.9153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 17.06.2026. Verfasst von Yinghua Geng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233000, P.R. China. Hauptthemen laut MEDLINE: Sulfonamides, Leukemia, Myeloid, Acute, Bridged Bicyclo Compounds, Heterocyclic, Proto-Oncogene Proteins c-bcl-2. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui 233000, P.R. China.
- Department of Biochemistry and Molecular Biology, Bengbu Medical University, Bengbu, Anhui 233030, P.R. China.
Zitieren
APA
Geng, Y., Zhou, L., Lou, Y., Chen, J., Liu, Q., Shen, J., Yang, Y., & Wu, W. (2026). PI3Kδ inhibitor YY‑20394 is effective alone or in combination with Bcl‑2 inhibitor ABT199 in acute myeloid leukemia cells. Oncology Reports, 56(2), 1-11. https://doi.org/10.3892/or.2026.9153
Vancouver
Geng Y, Zhou L, Lou Y, Chen J, Liu Q, Shen J, et al. PI3Kδ inhibitor YY‑20394 is effective alone or in combination with Bcl‑2 inhibitor ABT199 in acute myeloid leukemia cells. Oncology Reports. 2026;56(2):1-11. doi:10.3892/or.2026.9153
BibTeX
@article{Geng2026,
author = {Geng, Yinghua and Zhou, Lili and Lou, Yan and Chen, Jiaqi and Liu, Qi and Shen, Ji and Yang, Yanli and Wu, Wenjuan},
title = {PI3Kδ inhibitor YY‑20394 is effective alone or in combination with Bcl‑2 inhibitor ABT199 in acute myeloid leukemia cells},
journal = {Oncology Reports},
year = {2026},
volume = {56},
number = {2},
pages = {1--11},
doi = {10.3892/or.2026.9153}
}
EUVIMED